Lex Fridman avatar

Dexa/Lex Fridman

Learn more

Regaining Public Trust

Albert discusses the fragile nature of reputation in the pharmaceutical industry, emphasizing that while it can be lost quickly, rebuilding it takes time and consistent effort. He reflects on the lessons learned from the COVID pandemic, highlighting the critical role of the private sector in delivering solutions. Addressing past controversies, he acknowledges the challenges faced by Pfizer and the importance of maintaining integrity in their actions moving forward.